1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. SYROS PHARMACEUTICALS INC.
Syros Pharmaceuticals Inc. XNAS: SYRS

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Syros Pharmaceuticals Inc. is on 31 Jul 2025 for the purpose of Syros Pharmaceuticals Inc Second Quarter Earnings Results for 2025 See details


Insider Trading disclosures for Syros Pharmaceuticals Inc.

The latest disclosure was made by Simonian Nancy A. in Syros Pharmaceuticals Inc. where a trade of 37,070 Common Stock done at an average price of $0.3 was reported to US exchanges on Dec. 2, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Simonian Nancy A. Director 02 Dec 2024 37,070 4,000 (0%) 0% 0.3 10,016 Common Stock
Simonian A. Nancy Director 25 Nov 2024 134,713 41,070 (0%) 0% 0.3 35,739 Common Stock
Gerald E. Quirk Chief Legal & Compliance Offic 19 Nov 2024 46,657 0 (0%) 0% 0.2 10,321 Common Stock
David A. Roth Chief Medical Officer Sale of securities on an exchange or to another person at price $ 0.20 per share. 18 Nov 2024 12,099 0 (0%) 0% 0.2 2,382 Common Stock
Kristin Stephens Chief Development Officer Sale of securities on an exchange or to another person at price $ 0.22 per share. 18 Nov 2024 36,133 0 (0%) 0% 0.2 7,949 Common Stock
Conley Chee Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.20 per share. 18 Nov 2024 134,797 0 (0%) 0% 0.2 26,932 Common Stock
Jason Haas Chief Financial Officer Sale of securities on an exchange or to another person at price $ 0.21 per share. 18 Nov 2024 137,803 0 (0%) 0% 0.2 28,980 Common Stock
Nancy A. Simonian Director 31 Oct 2024 40,125 0 - - Restricted Stock Units
Nancy A. Simonian Director 31 Oct 2024 40,125 175,783 (0%) 0% - Common Stock
David A. Roth Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.09 per share. 31 Oct 2024 6,776 12,099 (0%) 0% 2.1 14,162 Common Stock
David A. Roth Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Oct 2024 18,875 0 - - Restricted Stock Units
David A. Roth Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Oct 2024 18,875 18,875 (0%) 0% - Common Stock
Kristin Stephens Chief Development Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.09 per share. 31 Oct 2024 6,104 36,133 (0%) 0% 2.1 12,757 Common Stock
Kristin Stephens Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Oct 2024 17,000 42,237 (0%) 0% - Common Stock
Kristin Stephens Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Oct 2024 17,000 0 - - Restricted Stock Units
Conley Chee Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Oct 2024 17,000 0 - - Restricted Stock Units
Conley Chee Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Oct 2024 17,000 139,504 (0%) 0% - Common Stock
Conley Chee Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.09 per share. 31 Oct 2024 8,707 130,797 (0%) 0% 2.1 18,198 Common Stock
Jason Haas Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Oct 2024 18,875 0 - - Restricted Stock Units
Jason Haas Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.09 per share. 31 Oct 2024 5,624 137,803 (0%) 0% 2.1 11,754 Common Stock
Jason Haas Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Oct 2024 18,875 143,427 (0%) 0% - Common Stock
Gerald E. Quirk Chief Legal & Compliance Offic 30 Sep 2024 10,000 49,757 (0%) 0% - Common Stock
Gerald E. Quirk Chief Legal & Compliance Offic 30 Sep 2024 10,000 20,000 - - Restricted Stock Units
Gerald E. Quirk Chief Legal & Compliance Offic 30 Sep 2024 3,100 46,657 (0%) 0% 2.1 6,510 Common Stock
Srinivas Akkaraju Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Sep 2024 2,667 2,667 - - Restricted Stock Units
Srinivas Akkaraju Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Sep 2024 2,667 9,333 (0%) 0% - Common Stock
Richard A. Young Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Sep 2024 2,667 2,667 - - Restricted Stock Units
Richard A. Young Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Sep 2024 2,667 10,667 (0%) 0% - Common Stock
Conley Chee Director, President & CEO Purchase of securities on an exchange or from another person at price $ 1.71 per share. 10 Sep 2024 50,000 122,504 (0%) 0% 1.7 85,420 Common Stock
Conley Chee Director, President & CEO Purchase of securities on an exchange or from another person at price $ 1.51 per share. 10 Sep 2024 50,000 72,504 (0%) 0% 1.5 75,260 Common Stock
Jason Haas Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 1.58 per share. 10 Sep 2024 19,293 79,208 (0%) 0% 1.6 30,446 Common Stock
Jason Haas Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 1.55 per share. 10 Sep 2024 35,363 59,915 (0%) 0% 1.5 54,788 Common Stock
Jason Haas Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 1.68 per share. 10 Sep 2024 45,344 124,552 (0%) 0% 1.7 76,006 Common Stock
Richard A. Young Director Sale of securities on an exchange or to another person at price $ 5.12 per share. 28 Jun 2024 34,837 8,000 (0%) 0% 5.1 178,365 Common Stock
Deborah L. Dunsire Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 6,000 6,000 - - Stock Option (right to buy)
Deborah L. Dunsire Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 4,000 4,000 - - Restricted Stock Units
Marsha H. Fanucci Director 05 Jun 2024 4,000 16,000 (0%) 0% 0 Common Stock
Marsha H. Fanucci Director 05 Jun 2024 6,000 6,000 - - Stock Option (right to buy)
Nancy A. Simonian Director 05 Jun 2024 6,000 6,000 - - Stock Option (right to buy)
Nancy A. Simonian Director 05 Jun 2024 4,000 135,658 (0%) 0% 0 Common Stock
Peter Wirth Director 05 Jun 2024 6,000 6,000 - - Stock Option (right to buy)
Peter Wirth Director 05 Jun 2024 4,000 16,000 (0%) 0% 0 Common Stock
Timothy C. Tyson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 6,000 6,000 - - Stock Option (right to buy)
Timothy C. Tyson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 4,000 33,189 (0%) 0% 0 Common Stock
Srinivas Akkaraju Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 4,000 4,000 - - Restricted Stock Units
Srinivas Akkaraju Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 6,000 6,000 - - Stock Option (right to buy)
Richard A. Young Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 4,000 42,837 (0%) 0% 0 Common Stock
Richard A. Young Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 6,000 6,000 - - Stock Option (right to buy)
Sue Gail Eckhardt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 4,000 16,000 (0%) 0% 0 Common Stock
Sue Gail Eckhardt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 6,000 6,000 - - Stock Option (right to buy)
Deborah L. Dunsire Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jun 2024 4,000 0 - - Restricted Stock Units
Deborah L. Dunsire Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jun 2024 4,000 12,000 (0%) 0% - Common Stock
Srinivas Akkaraju Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jun 2024 4,000 0 - - Restricted Stock Units
Srinivas Akkaraju Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jun 2024 4,000 6,666 (0%) 0% - Common Stock
David A. Roth Chief Medical Officer Sale of securities on an exchange or to another person at price $ 4.95 per share. 03 Apr 2024 10,451 0 (0%) 0% 4.9 51,732 Common Stock
Nancy A. Simonian Director 31 Mar 2024 6,000 106,144 (0%) 0% - Common Stock
Nancy A. Simonian Director 31 Mar 2024 39,566 79,134 - - Restricted Stock Units
Nancy A. Simonian Director 31 Mar 2024 6,000 12,000 - - Restricted Stock Units
Nancy A. Simonian Director 31 Mar 2024 14,052 131,658 (0%) 0% 5.1 71,946 Common Stock
Nancy A. Simonian Director 31 Mar 2024 39,566 145,710 (0%) 0% - Common Stock
David A. Roth Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2024 2,000 4,000 - - Restricted Stock Units
David A. Roth Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2024 2,000 2,000 (0%) 0% - Common Stock
David A. Roth Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2024 13,333 15,333 (0%) 0% - Common Stock
David A. Roth Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.12 per share. 31 Mar 2024 4,732 10,601 (0%) 0% 5.1 24,228 Common Stock
David A. Roth Chief Medical Officer Sale of securities on an exchange or to another person at price $ 4.98 per share. 31 Mar 2024 150 10,451 (0%) 0% 5.0 747 Common Stock
David A. Roth Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2024 13,333 26,667 - - Restricted Stock Units
Kristin Stephens Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2024 11,666 23,334 - - Restricted Stock Units
Kristin Stephens Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2024 2,000 4,000 - - Restricted Stock Units
Kristin Stephens Chief Development Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.12 per share. 31 Mar 2024 4,218 25,237 (0%) 0% 5.1 21,596 Common Stock
Kristin Stephens Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2024 2,000 17,789 (0%) 0% - Common Stock
Kristin Stephens Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2024 11,666 29,455 (0%) 0% - Common Stock
Conley Chee Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2024 11,666 23,334 - - Restricted Stock Units
Conley Chee Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2024 2,000 4,000 - - Restricted Stock Units
Conley Chee Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.12 per share. 31 Mar 2024 3,500 22,504 (0%) 0% 5.1 17,920 Common Stock
Conley Chee Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2024 2,000 14,338 (0%) 0% - Common Stock
Conley Chee Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2024 11,666 26,004 (0%) 0% - Common Stock
Jason Haas Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2024 2,000 15,951 (0%) 0% - Common Stock
Jason Haas Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.12 per share. 31 Mar 2024 4,732 24,552 (0%) 0% 5.1 24,228 Common Stock
Jason Haas Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2024 2,000 4,000 - - Restricted Stock Units
Jason Haas Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2024 13,333 26,667 - - Restricted Stock Units
Jason Haas Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2024 13,333 29,284 (0%) 0% - Common Stock
Gerald E. Quirk Chief Legal & Compliance Offic 27 Mar 2024 7,046 39,757 (0%) 0% 5.6 39,387 Common Stock
Gerald E. Quirk Chief Legal & Compliance Offic 27 Mar 2024 22,500 46,803 (0%) 0% - Common Stock
Gerald E. Quirk Chief Legal & Compliance Offic 27 Mar 2024 22,500 0 - - Restricted Stock Units
Srinivas Akkaraju Director Purchase of securities on an exchange or from another person at price $ 4.42 per share. 21 Dec 2023 904,977 1,786,427 (4%) 2% 4.4 3,999,998 Common Stock
David A. Roth Chief Medical Officer Sale of securities on an exchange or to another person at price $ 4.95 per share. 12 Dec 2023 6,287 0 (0%) 0% 5.0 31,121 Common Stock
A. Roth David Chief Medical Officer Sale of securities on an exchange or to another person at price $ 3.95 per share. 06 Dec 2023 6,287 6,287 (0%) 0% 4.0 24,834 Common Stock
Conley Chee Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Dec 2023 86,000 86,000 - - Restricted Stock Units
Simonian Nancy A. Director 01 Dec 2023 7,500 0 - - Stock Option (right to buy)
A. Simonian Nancy Director 01 Dec 2023 30,399 0 - - Stock Option (right to buy)
Simonian A. Nancy Director 01 Dec 2023 17,499 0 - - Stock Option (right to buy)
Nancy Simonian A. Director 01 Dec 2023 29,399 0 - - Stock Option (right to buy)
A. Simonian Nancy Director 01 Dec 2023 28,001 0 - - Stock Option (right to buy)
David A. Roth Chief Medical Officer Sale of securities on an exchange or to another person at price $ 3.95 per share. 31 Jul 2023 7,348 0 (0%) 0% 4.0 29,025 Common Stock
Eric R. Olson Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 3.50 per share. 17 Jul 2023 689 6,661 (0%) 0% 3.5 2,412 Common Stock
Deborah L. Dunsire Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 6,000 6,000 - - Stock Option (right to buy)
Deborah L. Dunsire Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 4,000 4,000 - - Restricted Stock Units
Marsha H. Fanucci Director 01 Jun 2023 6,000 6,000 - - Stock Option (right to buy)
Marsha H. Fanucci Director 01 Jun 2023 4,000 12,000 (0%) 0% 0 Common Stock
Peter Wirth Director 01 Jun 2023 6,000 6,000 - - Stock Option (right to buy)
Peter Wirth Director 01 Jun 2023 4,000 12,000 (0%) 0% 0 Common Stock
Timothy C. Tyson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 4,000 29,189 (0%) 0% 0 Common Stock
Timothy C. Tyson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 6,000 6,000 - - Stock Option (right to buy)
Srinivas Akkaraju Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 6,000 6,000 - - Stock Option (right to buy)
Srinivas Akkaraju Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 4,000 4,000 - - Restricted Stock Units
Richard A. Young Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 6,000 6,000 - - Stock Option (right to buy)
Richard A. Young Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 4,000 36,171 (0%) 0% 0 Common Stock
Mark J. Alles Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 4,000 4,000 - - Restricted Stock Units
Mark J. Alles Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 6,000 6,000 - - Stock Option (right to buy)
Sue Gail Eckhardt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 6,000 6,000 - - Stock Option (right to buy)
Sue Gail Eckhardt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 4,000 12,000 (0%) 0% 0 Common Stock
Nancy A. Simonian Director, President & CEO 31 Mar 2023 6,000 75,272 (0%) 0% - Common Stock
Nancy A. Simonian Director, President & CEO 31 Mar 2023 1,852 73,420 (0%) 0% 2.6 4,778 Common Stock
Nancy A. Simonian Director, President & CEO 31 Mar 2023 6,000 18,000 - - Restricted Stock Units
David A. Roth Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.58 per share. 31 Mar 2023 623 7,348 (0%) 0% 2.6 1,607 Common Stock
David A. Roth Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2023 2,000 7,971 (0%) 0% - Common Stock
David A. Roth Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2023 2,000 6,000 - - Restricted Stock Units
Eric R. Olson Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2023 2,000 7,973 (0%) 0% - Common Stock
Eric R. Olson Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2023 2,000 6,000 - - Restricted Stock Units
Eric R. Olson Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.58 per share. 31 Mar 2023 623 7,350 (0%) 0% 2.6 1,607 Common Stock
Kristin Stephens Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2023 2,000 5,088 (0%) 0% - Common Stock
Kristin Stephens Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2023 2,000 6,000 - - Restricted Stock Units
Kristin Stephens Chief Development Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.58 per share. 31 Mar 2023 623 4,465 (0%) 0% 2.6 1,607 Common Stock
Conley Chee Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2023 2,000 6,000 - - Restricted Stock Units
Conley Chee Chief Commercial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.58 per share. 31 Mar 2023 658 1,342 (0%) 0% 2.6 1,698 Common Stock
Conley Chee Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2023 2,000 2,000 (0%) 0% - Common Stock
Jason Haas Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2023 2,000 6,000 - - Restricted Stock Units
Jason Haas Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.58 per share. 31 Mar 2023 623 1,377 (0%) 0% 2.6 1,607 Common Stock
Jason Haas Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2023 2,000 2,000 (0%) 0% - Common Stock
Nancy A. Simonian Director, President & CEO 16 Feb 2023 118,700 118,700 - - Restricted Stock Units
David A. Roth Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2023 40,000 40,000 - - Restricted Stock Units
Eric R. Olson Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2023 35,000 35,000 - - Restricted Stock Units
Kristin Stephens Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2023 35,000 35,000 - - Restricted Stock Units
Conley Chee Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2023 35,000 35,000 - - Restricted Stock Units
Jason Haas Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2023 40,000 40,000 - - Restricted Stock Units
Gerald E. Quirk Chief Legal Officer 11 Oct 2022 45,000 45,000 - - Restricted Stock Units
Nancy A. Simonian Director, President & CEO 06 Oct 2022 115,000 115,000 - - Stock Option (right to buy)
Nancy A. Simonian Director, President & CEO 06 Oct 2022 80,250 80,250 - - Restricted Stock Units
David A. Roth Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2022 49,750 49,750 - - Stock Option (right to buy)
David A. Roth Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2022 37,750 37,750 - - Restricted Stock Units
Eric R. Olson Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2022 44,500 44,500 - - Stock Option (right to buy)
Eric R. Olson Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2022 34,000 34,000 - - Restricted Stock Units
Kristin Stephens Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2022 34,000 34,000 - - Restricted Stock Units
Kristin Stephens Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2022 44,500 44,500 - - Stock Option (right to buy)
Conley Chee Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2022 44,500 44,500 - - Stock Option (right to buy)
Conley Chee Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2022 34,000 34,000 - - Restricted Stock Units
Jason Haas Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2022 37,750 37,750 - - Restricted Stock Units
Jason Haas Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2022 49,750 49,750 - - Stock Option (right to buy)
Timothy C. Tyson Director Purchase of securities on an exchange or from another person at price $ 6.37 per share. 29 Sep 2022 14,000 24,932 (0%) 0% 6.4 89,186 Common Stock
Timothy C. Tyson Director Purchase of securities on an exchange or from another person at price $ 5.72 per share. 29 Sep 2022 2,932 10,932 (0%) 0% 5.7 16,770 Common Stock
Deborah L. Dunsire Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2022 12,000 12,000 - - Stock Option (right to buy)
Deborah L. Dunsire Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2022 8,000 8,000 (0%) 0% 0 Common Stock
Marsha H. Fanucci Director 16 Sep 2022 8,000 8,000 (0%) 0% 0 Common Stock
Marsha H. Fanucci Director 16 Sep 2022 12,000 12,000 - - Stock Option (right to buy)
Peter Wirth Director 16 Sep 2022 12,000 12,000 - - Stock Option (right to buy)
Peter Wirth Director 16 Sep 2022 8,000 8,000 (0%) 0% 0 Common Stock
Timothy C. Tyson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2022 3,286 3,286 - - Stock Option (right to buy)
Timothy C. Tyson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2022 8,000 8,000 (0%) 0% 0 Common Stock
Timothy C. Tyson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2022 257 8,257 (0%) 0% - Common Stock
Timothy C. Tyson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2022 12,000 12,000 - - Stock Option (right to buy)
Timothy C. Tyson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2022 2,232 2,232 - - Stock Option (right to buy)
Timothy C. Tyson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2022 1,094 1,094 - - Stock Option (right to buy)
Timothy C. Tyson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2022 2,191 2,191 - - Stock Option (right to buy)
Timothy C. Tyson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2022 2,191 2,191 - - Stock Option (right to buy)
Timothy C. Tyson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2022 2,848 2,848 - - Stock Option (right to buy)
Timothy C. Tyson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2022 3,856 3,856 - - Stock Option (right to buy)
Timothy C. Tyson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2022 3,856 3,856 - - Stock Option (right to buy)
Srinivas Akkaraju Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2022 691,489 691,489 - - Warrants (right to buy)
Srinivas Akkaraju Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2022 8,000 8,000 - - Restricted Stock Units
Srinivas Akkaraju Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2022 12,000 12,000 - - Stock Option (right to buy)
Srinivas Akkaraju Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2022 691,489 881,450 (2%) 1% - Common Stock
Richard A. Young Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2022 8,000 8,000 - - Restricted Stock Units
Richard A. Young Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2022 12,000 12,000 - - Stock Option (right to buy)
Mark J. Alles Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2022 12,000 12,000 - - Stock Option (right to buy)
Mark J. Alles Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2022 8,000 8,000 - - Restricted Stock Units
Sue Gail Eckhardt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2022 12,000 12,000 - - Stock Option (right to buy)
Sue Gail Eckhardt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2022 8,000 8,000 (0%) 0% 0 Common Stock
Deborah L. Dunsire Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 17,500 17,500 - - Stock Option (right to buy)
Marsha H. Fanucci Director 01 Jun 2022 17,500 17,500 - - Stock Option (right to buy)
Phillip A. Sharp Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 17,500 17,500 - - Stock Option (right to buy)
Peter Wirth Director 01 Jun 2022 17,500 17,500 - - Stock Option (right to buy)
Srinivas Akkaraju Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 17,500 17,500 - - Stock Option (right to buy)
Richard A. Young Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 17,500 17,500 - - Stock Option (right to buy)
Mark J. Alles Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 17,500 17,500 - - Stock Option (right to buy)
Amir H. Nashat Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 17,500 17,500 - - Stock Option (right to buy)
Sue Gail Eckhardt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 17,500 17,500 - - Stock Option (right to buy)
Nancy A. Simonian Director, President & CEO 01 Apr 2022 58,883 692,723 (1%) 0% 1.1 65,949 Common Stock
David A. Roth Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.12 per share. 01 Apr 2022 27,281 59,719 (0%) 0% 1.1 30,555 Common Stock
Eric R. Olson Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.12 per share. 01 Apr 2022 27,266 59,734 (0%) 0% 1.1 30,538 Common Stock
Kristin Stephens Chief Development Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.12 per share. 01 Apr 2022 14,115 30,885 (0%) 0% 1.1 15,809 Common Stock
Nancy A. Simonian Director, President & CEO 15 Feb 2022 375,000 375,000 - - Stock Option (right to buy)
Nancy A. Simonian Director, President & CEO 15 Feb 2022 400,000 400,000 - - Restricted Stock Units
Nancy A. Simonian Director, President & CEO 15 Feb 2022 240,000 240,000 - - Restricted Stock Units
David A. Roth Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 200,000 200,000 - - Restricted Stock Units
David A. Roth Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 80,000 80,000 - - Restricted Stock Units
David A. Roth Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 125,000 125,000 - - Stock Option (right to buy)
Eric R. Olson Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 100,000 100,000 - - Stock Option (right to buy)
Eric R. Olson Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 80,000 80,000 - - Restricted Stock Units
Eric R. Olson Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 200,000 200,000 - - Restricted Stock Units
Kristin Stephens Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 80,000 80,000 - - Restricted Stock Units
Kristin Stephens Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 200,000 200,000 - - Restricted Stock Units
Kristin Stephens Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 100,000 100,000 - - Stock Option (right to buy)
Conley Chee Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 80,000 80,000 - - Restricted Stock Units
Conley Chee Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 100,000 100,000 - - Stock Option (right to buy)
Jason Haas Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 125,000 125,000 - - Stock Option (right to buy)
Jason Haas Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 80,000 80,000 - - Restricted Stock Units
Eric R. Olson Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 3.47 per share. 05 Jan 2022 2,208 0 (0%) 0% 3.5 7,655 Common Stock
Jason Haas Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Oct 2021 750,000 750,000 - - Stock Option (right to buy)
Conley Chee Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Sep 2021 360,000 360,000 - - Stock Option (right to buy)
Eric R. Olson Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 5.55 per share. 01 Jul 2021 1,164 0 (0%) 0% 5.5 6,460 Common Stock
Marsha H. Fanucci Director 08 Jun 2021 17,500 17,500 - - Stock Option (right to buy)
Phillip A. Sharp Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2021 17,500 17,500 - - Stock Option (right to buy)
Peter Wirth Director 08 Jun 2021 17,500 17,500 - - Stock Option (right to buy)
Srinivas Akkaraju Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2021 17,500 17,500 - - Stock Option (right to buy)
Richard A. Young Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2021 17,500 17,500 - - Stock Option (right to buy)
Mark J. Alles Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2021 17,500 17,500 - - Stock Option (right to buy)
Amir H. Nashat Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2021 17,500 17,500 - - Stock Option (right to buy)
Sue Gail Eckhardt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2021 17,500 17,500 - - Stock Option (right to buy)
Eric R. Olson Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.01 per share. 15 Mar 2021 3,628 3,628 (0%) 0% 1.0 3,664 Common Stock
Eric R. Olson Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 9.47 per share. 15 Mar 2021 3,628 0 (0%) 0% 9.5 34,372 Common Stock
Eric R. Olson Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Mar 2021 3,628 90,697 - - Stock Option (right to buy)
Nancy A. Simonian Director, President & CEO 17 Feb 2021 304,000 304,000 - - Stock Option (right to buy)
Gerald E. Quirk Chief Legal & Admin. Officer 17 Feb 2021 94,000 94,000 - - Stock Option (right to buy)
David A. Roth Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2021 119,000 119,000 - - Stock Option (right to buy)
Eric R. Olson Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2021 94,000 94,000 - - Stock Option (right to buy)
Jeremy P. Springhorn Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2021 94,000 94,000 - - Stock Option (right to buy)
Joseph J. Ferra Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2021 119,000 119,000 - - Stock Option (right to buy)
Richard A. Young Director Sale of securities on an exchange or to another person at price $ 12.05 per share. 16 Feb 2021 3,750 321,711 (0%) 0% 12.1 45,188 Common Stock
Richard A. Young Director Sale of securities on an exchange or to another person at price $ 13.04 per share. 08 Feb 2021 3,750 325,461 (0%) 0% 13.0 48,900 Common Stock
Nancy A. Simonian Director, President & CEO 18 Dec 2020 10,761 544,450 (1%) 0% 3.0 32,713 Common Stock
Nancy A. Simonian Director, President & CEO 18 Dec 2020 4,988 280,012 - - Stock Option (right to buy)
Nancy A. Simonian Director, President & CEO 18 Dec 2020 14,168 79,165 - - Stock Option (right to buy)
Nancy A. Simonian Director, President & CEO 18 Dec 2020 10,761 21,524 - - Stock Option (right to buy)
Nancy A. Simonian Director, President & CEO 18 Dec 2020 4,988 563,606 (1%) 0% 10.1 50,329 Common Stock
Nancy A. Simonian Director, President & CEO 18 Dec 2020 14,168 558,618 (1%) 0% 8.5 120,570 Common Stock
Richard A. Young Director Sale of securities on an exchange or to another person at price $ 8.75 per share. 16 Nov 2020 5,357 339,211 (0%) 0% 8.8 46,874 Common Stock
Richard A. Young Director Sale of securities on an exchange or to another person at price $ 8.98 per share. 16 Nov 2020 633 344,568 (0%) 0% 9.0 5,684 Common Stock
Richard A. Young Director Sale of securities on an exchange or to another person at price $ 8.75 per share. 19 Oct 2020 5,673 335,201 (0%) 0% 8.8 49,639 Common Stock
Richard A. Young Director Sale of securities on an exchange or to another person at price $ 8.75 per share. 15 Oct 2020 317 340,874 (0%) 0% 8.8 2,774 Common Stock
Richard A. Young Director Sale of securities on an exchange or to another person at price $ 10.39 per share. 15 Sep 2020 5,990 341,191 (0%) 0% 10.4 62,236 Common Stock
Sue Gail Eckhardt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Sep 2020 35,000 35,000 - - Stock Option (right to buy)
Srinivas Akkaraju Director Sale of securities on an exchange or to another person at price $ 13.00 per share. 17 Aug 2020 744 1,433,199 (3%) 0% 13 9,672 Common Stock
Srinivas Akkaraju Director Sale of securities on an exchange or to another person at price $ 13.10 per share. 17 Aug 2020 158,583 1,274,616 (2%) 0% 13.1 2,076,724 Common Stock
Richard A. Young Director Sale of securities on an exchange or to another person at price $ 12.59 per share. 17 Aug 2020 5,990 347,181 (0%) 0% 12.6 75,414 Common Stock
Eric R. Olson Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 13.00 per share. 17 Aug 2020 10,787 0 (0%) 0% 13 140,231 Common Stock
Eric R. Olson Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.01 per share. 17 Aug 2020 10,787 10,787 (0%) 0% 1.0 10,895 Common Stock
Eric R. Olson Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 13.00 per share. 17 Aug 2020 4,963 0 (0%) 0% 13 64,519 Common Stock
Eric R. Olson Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.01 per share. 17 Aug 2020 4,963 4,963 (0%) 0% 1.0 5,013 Common Stock
Eric R. Olson Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Aug 2020 10,787 94,325 - - Stock Option (right to buy)
Eric R. Olson Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Aug 2020 4,963 105,112 - - Stock Option (right to buy)
Richard A. Young Director Sale of securities on an exchange or to another person at price $ 11.85 per share. 15 Jul 2020 5,990 353,171 (0%) 0% 11.9 70,982 Common Stock
Eric R. Olson Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 11.72 per share. 07 Jul 2020 1,753 0 (0%) 0% 11.7 20,538 Common Stock
Srinivas Akkaraju Director Sale of securities on an exchange or to another person at price $ 11.01 per share. 01 Jul 2020 4,627 1,433,943 (3%) 0% 11.0 50,966 Common Stock
Srinivas Akkaraju Director Sale of securities on an exchange or to another person at price $ 11.15 per share. 23 Jun 2020 54,972 1,438,570 (3%) 0% 11.1 612,850 Common Stock
Srinivas Akkaraju Director Sale of securities on an exchange or to another person at price $ 11.07 per share. 23 Jun 2020 48,775 1,493,542 (3%) 0% 11.1 539,788 Common Stock
Srinivas Akkaraju Director Sale of securities on an exchange or to another person at price $ 11.11 per share. 23 Jun 2020 50,953 1,542,317 (3%) 0% 11.1 565,930 Common Stock
Richard A. Young Director Sale of securities on an exchange or to another person at price $ 8.75 per share. 15 Jun 2020 5,990 359,161 (0%) 0% 8.8 52,413 Common Stock
Marsha H. Fanucci Director 11 Jun 2020 17,500 17,500 - - Stock Option (right to buy)
Phillip A. Sharp Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2020 17,500 17,500 - - Stock Option (right to buy)
Peter Wirth Director 11 Jun 2020 17,500 17,500 - - Stock Option (right to buy)
Srinivas Akkaraju Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2020 17,500 17,500 - - Stock Option (right to buy)
Richard A. Young Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2020 17,500 17,500 - - Stock Option (right to buy)
Mark J. Alles Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2020 17,500 17,500 - - Stock Option (right to buy)
Amir H. Nashat Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2020 17,500 17,500 - - Stock Option (right to buy)
Richard A. Young Director Sale of securities on an exchange or to another person at price $ 9.22 per share. 15 May 2020 5,990 365,151 (0%) 0% 9.2 55,242 Common Stock
Mark J. Alles Director Purchase of securities on an exchange or from another person at price $ 8.86 per share. 13 May 2020 10,000 10,000 (0%) 0% 8.9 88,590 Common Stock
Richard A. Young Director Sale of securities on an exchange or to another person at price $ 8.75 per share. 15 Apr 2020 23,960 371,141 (0%) 0% 8.8 209,650 Common Stock
Eric R. Olson Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 7.38 per share. 18 Feb 2020 1,446 0 (0%) 0% 7.4 10,674 Common Stock
Nancy A. Simonian Director, President & CEO 13 Feb 2020 294,000 294,000 - - Stock Option (right to buy)
Gerald E. Quirk Chief Legal & Admin. Officer 13 Feb 2020 94,000 94,000 - - Stock Option (right to buy)
David A. Roth Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2020 94,000 94,000 - - Stock Option (right to buy)
Eric R. Olson Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2020 94,000 94,000 - - Stock Option (right to buy)
Jeremy P. Springhorn Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2020 94,000 94,000 - - Stock Option (right to buy)
Joseph J. Ferra Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2020 94,000 94,000 - - Stock Option (right to buy)
Nancy A. Simonian Director, President & CEO 23 Dec 2019 33,429 1,037,095 - - Stock Option (right to buy)
Nancy A. Simonian Director, President & CEO 23 Dec 2019 8,210 1,018,123 - - Stock Option (right to buy)
Nancy A. Simonian Director, President & CEO 23 Dec 2019 10,762 1,026,333 - - Stock Option (right to buy)
Nancy A. Simonian Director, President & CEO 23 Dec 2019 52,401 533,689 (1%) 0% 3.0 159,299 Common Stock
Mark J. Alles None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2019 35,000 35,000 - - Stock Option (right to buy)
Jeremy P. Springhorn Chief Business Officer Purchase of securities on an exchange or from another person at price $ 4.97 per share. 11 Nov 2019 10,121 35,000 (0%) 0% 5.0 50,268 Common Stock
Jeremy P. Springhorn Chief Business Officer Purchase of securities on an exchange or from another person at price $ 4.99 per share. 11 Nov 2019 9,879 24,879 (0%) 0% 5.0 49,328 Common Stock
Richard A. Young None Sale of securities on an exchange or to another person at price $ 10.00 per share. 15 Aug 2019 2,300 417,801 (0%) 0% 10 23,000 Common Stock
Richard A. Young None Sale of securities on an exchange or to another person at price $ 10.00 per share. 15 Aug 2019 22,700 395,101 (0%) 0% 10 227,000 Common Stock
Marsha H. Fanucci None 11 Jun 2019 11,000 11,000 - - Common Stock (right to buy)
Michael W. Bonney None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2019 11,000 11,000 - - Stock Option (right to buy)
Phillip A. Sharp None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2019 11,000 11,000 - - Stock Option (right to buy)
Vicki L. Sato None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2019 11,000 11,000 - - Common Stock (right to buy)
Peter Wirth None 11 Jun 2019 11,000 11,000 - - Stock Option (right to buy)
Srinivas Akkaraju None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2019 11,000 11,000 - - Stock Option (right to buy)
Richard A. Young None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2019 11,000 11,000 - - Stock Option (right to buy)
Amir H. Nashat None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2019 11,000 11,000 - - Stock Option (right to buy)
Alice Tsang Shaw None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2019 22,000 22,000 - - Stock Option (right to buy)
Srinivas Akkaraju None Purchase of securities on an exchange or from another person at price $ 7.50 per share. 09 Apr 2019 533,332 1,593,270 (3%) 1% 7.5 3,999,990 Common Stock
Srinivas Akkaraju None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 Apr 2019 133,333 133,333 - - Common Stock Warrants (rights to buy)
Nancy A. Simonian Director, President & CEO 12 Feb 2019 188,000 669,288 (1%) 0% 0 Common Stock
Nancy A. Simonian Director, President & CEO 12 Feb 2019 285,000 285,000 - - Stock Option (right to buy)
Gerald E. Quirk Chief Legal & Admin. Officer 12 Feb 2019 87,000 87,000 (0%) 0% 0 Common Stock
Gerald E. Quirk Chief Legal & Admin. Officer 12 Feb 2019 75,000 75,000 - - Stock Option (right to buy)
David A. Roth Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2019 75,000 75,000 - - Stock Option (right to buy)
David A. Roth Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2019 87,000 87,000 (0%) 0% 0 Common Stock
Eric R. Olson Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2019 87,000 87,000 (0%) 0% 0 Common Stock
Eric R. Olson Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2019 75,000 75,000 - - Stock Option (right to buy)
Jeremy P. Springhorn Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2019 87,000 102,000 (0%) 0% 0 Common Stock
Jeremy P. Springhorn Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2019 75,000 75,000 - - Stock Option (right to buy)
Joseph J. Ferra Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2019 87,000 87,000 (0%) 0% 0 Common Stock
Joseph J. Ferra Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2019 75,000 75,000 - - Stock Option (right to buy)
Nancy A. Simonian Director, President & CEO 29 Nov 2018 12,084 481,288 (1%) 0% 3.0 36,735 Common Stock
Nancy A. Simonian Director, President & CEO 29 Nov 2018 23,454 872,657 - - Stock Option (right to buy)
Nancy A. Simonian Director, President & CEO 29 Nov 2018 75,050 797,607 - - Stock Option (right to buy)
Nancy A. Simonian Director, President & CEO 29 Nov 2018 12,084 785,523 - - Stock Option (right to buy)
Nancy A. Simonian Director, President & CEO 29 Nov 2018 98,504 469,204 (1%) 0% 1.0 99,489 Common Stock
Marsha H. Fanucci None 14 Jun 2018 11,000 11,000 - - Stock Option (right to buy)
Michael W. Bonney None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2018 13,000 13,000 - - Stock Option (right to buy)
Phillip A. Sharp None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2018 11,000 11,000 - - Stock Option (right to buy)
Vicki L. Sato None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2018 11,000 11,000 - - Stock Option (right to buy)
Peter Wirth None 14 Jun 2018 11,000 11,000 - - Stock Option (right to buy)
Srinivas Akkaraju None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2018 11,000 11,000 - - Stock Option (right to buy)
Richard A. Young None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2018 11,000 11,000 - - Stock Option (right to buy)
Amir H. Nashat None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2018 11,000 11,000 - - Stock Option (right to buy)
Joseph J. Ferra Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2018 50,000 50,000 - - Stock Option (right to buy)
Joseph J. Ferra Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2018 150,000 150,000 - - Stock Option (right to buy)
Nancy A. Simonian Director, President & CEO 16 Feb 2018 285,000 285,000 - - Stock Option (right to buy)
Gerald E. Quirk Chief Legal Officer 16 Feb 2018 11,666 11,666 - - Stock Option (right to buy)
Gerald E. Quirk Chief Legal Officer 16 Feb 2018 75,000 75,000 - - Stock Option (right to buy)
David A. Roth Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2018 75,000 75,000 - - Stock Option (right to buy)
Eric R. Olson Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2018 75,000 75,000 - - Stock Option (right to buy)
Srinivas Akkaraju None Purchase of securities on an exchange or from another person at price $ 9.55 per share. 31 Jan 2018 209,424 1,059,938 (3%) 0% 9.5 1,999,999 Common Stock
Noubar B. Afeyan Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 31 Dec 2017 24,527 0 (0%) 0% 0 Common Stock
Jeremy P. Springhorn Chief Business Officer Purchase of securities on an exchange or from another person at price $ 9.08 per share. 15 Dec 2017 15,000 15,000 (0%) 0% 9.1 136,260 Common Stock
Srinivas Akkaraju None Purchase of securities on an exchange or from another person at price $ 9.40 per share. 12 Dec 2017 14,774 735,494 (2%) 0% 9.4 138,876 Common Stock
Srinivas Akkaraju None Purchase of securities on an exchange or from another person at price $ 8.99 per share. 12 Dec 2017 26,600 830,494 (3%) 0% 9.0 239,134 Common Stock
Srinivas Akkaraju None Purchase of securities on an exchange or from another person at price $ 8.97 per share. 12 Dec 2017 68,400 803,894 (3%) 0% 9.0 613,548 Common Stock
Jeremy P. Springhorn Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Nov 2017 150,000 150,000 - - Stock Option (right to buy)
Jeremy P. Springhorn Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Nov 2017 50,000 50,000 - - Stock Option (right to buy)
Colleen DeSimone Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.04 per share. 23 Oct 2017 550 550 (0%) 0% 3.0 1,672 Common Stock
Colleen DeSimone Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Oct 2017 550 13,016 - - Stock Option (right to buy)
Colleen DeSimone Principal Accounting Officer Sale of securities on an exchange or to another person at price $ 16.06 per share. 23 Oct 2017 550 0 (0%) 0% 16.1 8,833 Common Stock
Richard A. Young None Sale of securities on an exchange or to another person at price $ 22.00 per share. 14 Aug 2017 3,282 420,101 (1%) 0% 22 72,204 Common Stock
Eric R. Olson Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 23.59 per share. 07 Aug 2017 2,500 0 (0%) 0% 23.6 58,969 Common Stock
Eric R. Olson Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.01 per share. 07 Aug 2017 2,500 2,500 (0%) 0% 1.0 2,525 Common Stock
Eric R. Olson Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Aug 2017 2,500 110,075 - - Stock Option (right to buy)
Richard A. Young None Sale of securities on an exchange or to another person at price $ 22.09 per share. 25 Jul 2017 3,282 423,383 (1%) 0% 22.1 72,496 Common Stock
Eric R. Olson Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.01 per share. 25 Jul 2017 12,500 12,500 (0%) 0% 1.0 12,625 Common Stock
Eric R. Olson Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jul 2017 12,500 25,025 - - Stock Option (right to buy)
Eric R. Olson Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 21.85 per share. 25 Jul 2017 12,500 0 (0%) 0% 21.9 273,125 Common Stock
Marsha H. Fanucci None 08 Jun 2017 11,000 11,000 - - Stock Option (right to buy)
Phillip A. Sharp None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2017 11,000 11,000 - - Stock Option (right to buy)
Robert T. Nelsen Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2017 11,000 11,000 - - Stock Option (right to buy)
Vicki L. Sato None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2017 11,000 11,000 - - Stock Option (right to buy)
Srinivas Akkaraju None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2017 22,000 22,000 - - Stock Option (right to buy)
Richard A. Young None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2017 11,000 11,000 - - Stock Option (right to buy)
Sanj K. Patel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2017 11,000 11,000 - - Stock Option (right to buy)
Amir H. Nashat None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2017 11,000 11,000 - - Stock Option (right to buy)
Nancy A. Simonian Director, President & CEO 10 Feb 2017 175,000 175,000 - - Stock Option (right to buy)
Gerald E. Quirk Chief Legal Officer 10 Feb 2017 40,000 40,000 - - Stock Option (right to buy)
Richard A. Young None Other type of transaction at price $ 0.00 per share. 10 Feb 2017 106,667 426,665 (1%) 0% 0 Common Stock
David A. Roth Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2017 63,500 63,500 - - Stock Option (right to buy)
Kyle D. Kuvalanka Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2017 78,000 78,000 - - Stock Option (right to buy)
Eric R. Olson Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2017 63,500 63,500 - - Stock Option (right to buy)
Peter Wirth None 27 Jan 2017 22,000 22,000 - - Stock Option (Right to Buy)
Gerald E. Quirk Chief Legal & Admin. Officer 27 Sep 2016 35,000 35,000 - - Stock Option (right to buy)
Nancy A. Simonian Director, President & CEO 16 Sep 2016 75,000 75,000 - - Stock Option (right to buy)
Marsha H. Fanucci Director 15 Sep 2016 22,000 22,000 - - Stock Option (right to buy)
Phillip A. Sharp Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2016 22,000 22,000 - - Stock Option (right to buy)
Robert Taylor Nelsen Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2016 22,000 22,000 - - Stock Option (right to buy)
Vicki L. Sato Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2016 22,000 22,000 - - Stock Option (right to buy)
Richard A. Young Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2016 22,000 22,000 - - Stock Option (right to buy)
Stephane Bancel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2016 22,000 22,000 - - Stock Option (right to buy)
Sanj K. Patel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2016 22,000 22,000 - - Stock Option (right to buy)
Amir H. Nashat Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2016 22,000 22,000 - - Stock Option (right to buy)
Phillip A. Sharp Director 06 Jul 2016 40,000 40,000 (0%) - - Common Stock
Phillip A. Sharp Director 06 Jul 2016 150,000 0 - - Series A-2 Preferred Stock
Phillip A. Sharp Director 06 Jul 2016 150,000 0 - - Series A-2 Preferred Stock
Phillip A. Sharp Director 06 Jul 2016 150,000 0 - - Series A-2 Preferred Stock
Phillip A. Sharp Director 06 Jul 2016 550,000 0 - - Series A-2 Preferred Stock
Phillip A. Sharp Director 06 Jul 2016 146,666 146,666 (0%) - - Common Stock
Phillip A. Sharp Director 06 Jul 2016 40,000 40,000 (0%) - - Common Stock
Phillip A. Sharp Director 06 Jul 2016 40,000 40,000 (0%) - - Common Stock
Robert Taylor Nelsen Director, Ten Percent Owner 06 Jul 2016 2,000,000 3,813,332 (8%) - - Common Stock
Robert Taylor Nelsen Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Jul 2016 400,000 4,637,137 (10%) - - Common Stock
Robert Taylor Nelsen Director, Ten Percent Owner 06 Jul 2016 423,805 4,237,137 (9%) - - Common Stock
Robert Taylor Nelsen Director, Ten Percent Owner 06 Jul 2016 1,333,333 1,813,332 (4%) - - Common Stock
Robert Taylor Nelsen Director, Ten Percent Owner 06 Jul 2016 266,666 479,999 (1%) - - Common Stock
Robert Taylor Nelsen Director, Ten Percent Owner 06 Jul 2016 1,000,000 0 - - Series A-1 Preferred Stock
Robert Taylor Nelsen Director, Ten Percent Owner 06 Jul 2016 5,000,000 0 - - Series A-2 Preferred Stock
Robert Taylor Nelsen Director, Ten Percent Owner 06 Jul 2016 7,500,000 0 - - Series A-3 Preferred Stock
Robert Taylor Nelsen Director, Ten Percent Owner 06 Jul 2016 1,589,269 0 - - Series B Preferred Stock
Nancy A. Simonian Director, President and CEO 06 Jul 2016 250,000 0 - - Series A-2 Preferred Stock
Nancy A. Simonian Director, President and CEO 06 Jul 2016 66,666 370,702 (0%) - - Common Stock
Flynn E James None 06 Jul 2016 1,186,654 0 - - Series B Convertible Preferred Stock
Flynn E James None 06 Jul 2016 1,186,654 1,186,654 (2%) - - Common Stock
Flynn E James None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Jul 2016 280,000 1,466,654 (3%) - - Common Stock
Flynn E James None 06 Jul 2016 508,566 508,566 (1%) - - Common Stock
Flynn E James None 06 Jul 2016 508,566 0 - - Series B Convertible Preferred Stock
Flynn E James None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Jul 2016 120,000 628,566 (1%) - - Common Stock
Stephane Bancel Director 06 Jul 2016 26,666 47,980 (0%) - - Common Stock
Stephane Bancel Director 06 Jul 2016 100,000 0 - - Series A-2 Preferred Stock
Amir H. Nashat Director, Ten Percent Owner 06 Jul 2016 83,129 0 - - Series B Preferred Stock
Amir H. Nashat Director, Ten Percent Owner 06 Jul 2016 4,366,825 0 - - Series B Preferred Stock
Amir H. Nashat Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Jul 2016 26,153 48,320 (0%) - - Common Stock
Amir H. Nashat Director, Ten Percent Owner 06 Jul 2016 22,167 22,167 (0%) - - Common Stock
Amir H. Nashat Director, Ten Percent Owner 06 Jul 2016 1,164,486 1,164,486 (2%) - - Common Stock
Amir H. Nashat Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Jul 2016 373,847 1,538,333 (3%) - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters